ArticleJournal of gastrointestinal oncology2024
Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort study.
Jialong Tao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.